
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
HONG KONG, Apr 24, 2025 – […]

WATERLOO, ONTARIO, Apr 23, 202 […]

KUALA LUMPUR, Apr 23, 2025  […]

HONG KONG, Apr 23, 2025 – […]
` tags. “ (SeaPRwire) – […]…

(SeaPRwire) – EPALINGE […]…
(SeaPRwire) – 上海, 2025 […]…
JAKARTA, Apr 21, 2025 – […]

Key Highlights: – Green […]

WELLINGTON, FL, Apr 22, 2025 & […]
SHANGHAI, Apr 22, 2025 – […]

Luxembourg, Apr 21, 2025 ̵ […]
Saudi Arabia, Apr 21, 2025  […]
Saudi Arabia, Apr 21, 2025  […]